anti mouse cd8 α (Bio X Cell)
Bio X Cell is a verified supplier 
Bio X Cell manufactures this product 
96
Structured Review
Bio X Cell
anti mouse cd8 α
Anti Mouse Cd8 α, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 205 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd8+%CE%B1/InVivoMAb+anti-mouse+CD8%CE%B2/pm42829916-411-4-19
Average 96 stars, based on 205 article reviews
Anti Mouse Cd8 α, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 205 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd8+%CE%B1/InVivoMAb+anti-mouse+CD8%CE%B2/pm42829916-411-4-19
Average 96 stars, based on 205 article reviews
anti mouse cd8 α - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
other:Article Title: Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy Article Snippet: CD8 T cells, NK cells, or neutrophils were depleted with 400 μg of In Vivo:Article Title: cGAS and STING in Host Myeloid Cells Are Essential for Effective Cyclophosphamide Treatment of Advanced Breast Cancer Article Snippet: Mice were inoculated with 0.5 × 10 6 E0771 cells into the right fourth mammary fat pad on day 0 and then injected intraperitoneally (ip) with 150 mg/kg body weight CTX (Sigma-Aldrich) on day 21 and day 27, unless stated otherwise. .. For depletion of T cells in vivo, mice received an ip injection of 0.2 mg anti-CD4 (GK1.5, RRID:AB_1107636, BioXcell, Lebanon, NH, USA), Article Title: Spatiotemporally engineered tumor-derived extracellular vesicle-based scaffold vaccine for personalized cancer immunotherapy. Article Snippet: Cells were subsequently assayed for IFN-γ by Elispot kit (Mabtech) and spot counts using instrument (BD Biosciences). .. In vivo T-cell depletion To deplete CD4+ T and CD8+ T cells, tumor-bearing mice were i.p. injected with anti-CD4 (clone GK1.5, BioXcell), Injection:Article Title: cGAS and STING in Host Myeloid Cells Are Essential for Effective Cyclophosphamide Treatment of Advanced Breast Cancer Article Snippet: Mice were inoculated with 0.5 × 10 6 E0771 cells into the right fourth mammary fat pad on day 0 and then injected intraperitoneally (ip) with 150 mg/kg body weight CTX (Sigma-Aldrich) on day 21 and day 27, unless stated otherwise. .. For depletion of T cells in vivo, mice received an ip injection of 0.2 mg anti-CD4 (GK1.5, RRID:AB_1107636, BioXcell, Lebanon, NH, USA), Article Title: Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel Article Snippet: To deplete NK cells, CD4 + T cells and CD8 + T cells, tumour-bearing mice were intraperitoneally injected with anti-NK1.1 (clone PK136, BioXCell), anti-CD4 (clone GK1.5, BioXCell), anti-CD8-α (clone 2.43, BioXCell) or isotype control (RatIgG1,BioXcell) antibodies at an initial dose of 400 mg 1 d before treatment, followed by 200 mg every 3 d. Depletion of CD8 + T cells, CD4 + T cells and NK cells was confirmed using flow cytometry analysis of peripheral blood mononuclear cells. .. To deplete NK cells, CD4 + T cells and CD8 + T cells, tumour-bearing mice were intraperitoneally injected with anti-NK1.1 (clone PK136, BioXCell), anti-CD4 (clone GK1.5, BioXCell), Article Title: Spatiotemporally engineered tumor-derived extracellular vesicle-based scaffold vaccine for personalized cancer immunotherapy. Article Snippet: Cells were subsequently assayed for IFN-γ by Elispot kit (Mabtech) and spot counts using instrument (BD Biosciences). .. In vivo T-cell depletion To deplete CD4+ T and CD8+ T cells, tumor-bearing mice were i.p. injected with anti-CD4 (clone GK1.5, BioXcell), Article Title: Supporting Information for Self-assembling paclitaxel-mediated stimulation of tumor-associated macrophages for postoperative treatment of glioblastoma Article Snippet: .. To deplete CD3+ T cells and CD8+ T cells, tumor-bearing mice were intraperitoneally injected with anti-CD3ε (clone 145-2C11, BioXCell) and Article Title: Bifidobacterium pseudocatenulatum capsular exopolysaccharide enhances systemic anti-tumour immunity in pre-clinical breast cancer Article Snippet: For checkpoint immunotherapy experiments, tumour-bearing animals were intraperitoneally administered 20mg/kg anti-PD-1 mAb (Clone J43, BioXCell, New Hampshire, USA) or matched isotype control on days 7, 10, 13. .. Cellular depletions were induced through intraperitoneal injection of 400μg Control:Article Title: cGAS and STING in Host Myeloid Cells Are Essential for Effective Cyclophosphamide Treatment of Advanced Breast Cancer Article Snippet: Mice were inoculated with 0.5 × 10 6 E0771 cells into the right fourth mammary fat pad on day 0 and then injected intraperitoneally (ip) with 150 mg/kg body weight CTX (Sigma-Aldrich) on day 21 and day 27, unless stated otherwise. .. For depletion of T cells in vivo, mice received an ip injection of 0.2 mg anti-CD4 (GK1.5, RRID:AB_1107636, BioXcell, Lebanon, NH, USA), Article Title: Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel Article Snippet: To deplete NK cells, CD4 + T cells and CD8 + T cells, tumour-bearing mice were intraperitoneally injected with anti-NK1.1 (clone PK136, BioXCell), anti-CD4 (clone GK1.5, BioXCell), anti-CD8-α (clone 2.43, BioXCell) or isotype control (RatIgG1,BioXcell) antibodies at an initial dose of 400 mg 1 d before treatment, followed by 200 mg every 3 d. Depletion of CD8 + T cells, CD4 + T cells and NK cells was confirmed using flow cytometry analysis of peripheral blood mononuclear cells. .. To deplete NK cells, CD4 + T cells and CD8 + T cells, tumour-bearing mice were intraperitoneally injected with anti-NK1.1 (clone PK136, BioXCell), anti-CD4 (clone GK1.5, BioXCell), Article Title: Supporting Information for Self-assembling paclitaxel-mediated stimulation of tumor-associated macrophages for postoperative treatment of glioblastoma Article Snippet: .. To deplete CD3+ T cells and CD8+ T cells, tumor-bearing mice were intraperitoneally injected with anti-CD3ε (clone 145-2C11, BioXCell) and Article Title: Bifidobacterium pseudocatenulatum capsular exopolysaccharide enhances systemic anti-tumour immunity in pre-clinical breast cancer Article Snippet: For checkpoint immunotherapy experiments, tumour-bearing animals were intraperitoneally administered 20mg/kg anti-PD-1 mAb (Clone J43, BioXCell, New Hampshire, USA) or matched isotype control on days 7, 10, 13. .. Cellular depletions were induced through intraperitoneal injection of 400μg Flow Cytometry:Article Title: Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel Article Snippet: To deplete NK cells, CD4 + T cells and CD8 + T cells, tumour-bearing mice were intraperitoneally injected with anti-NK1.1 (clone PK136, BioXCell), anti-CD4 (clone GK1.5, BioXCell), anti-CD8-α (clone 2.43, BioXCell) or isotype control (RatIgG1,BioXcell) antibodies at an initial dose of 400 mg 1 d before treatment, followed by 200 mg every 3 d. Depletion of CD8 + T cells, CD4 + T cells and NK cells was confirmed using flow cytometry analysis of peripheral blood mononuclear cells. .. To deplete NK cells, CD4 + T cells and CD8 + T cells, tumour-bearing mice were intraperitoneally injected with anti-NK1.1 (clone PK136, BioXCell), anti-CD4 (clone GK1.5, BioXCell), |
